CYTORI THERAPEUTICS, INC. Human Resources Contracts & Agreements
29 Contracts & Agreements
- Bonus & Incentive Agreements (12 contracts)
- Compensation Agreements (1)
- Consulting Agreements (3)
- Employment Agreements (7)
- Separation Agreements (1)
- Severance Agreements (5)
- Third Amendment to The Plus Therapeutics, Inc. 2015 New Employee Incentive Plan (Filed With SEC on June 7, 2024)
- Plus Therapeutics, Inc. 2020 Stock Incentive Plan, as further amended and restated (Filed With SEC on May 20, 2022)
- Form of Notice of Grant and Stock Option Agreement under the 2020 Stock Incentive Plan (Filed With SEC on February 24, 2022)
- LaFrance Employment Agreement, dated September 7, 2021 (Filed With SEC on September 13, 2021)
- Plus Therapeutics, Inc., 2020 Stock Incentive Plan, as amended and restated (Filed With SEC on May 20, 2021)
- Plus Therapeutics, Inc., 2020 Equity Incentive Plan (Filed With SEC on June 17, 2020)
- Amended and Restated Employment Agreement between Andrew Sims and Plus Therapeutics, Inc (Filed With SEC on May 14, 2020)
- Amended and Restated Employment Agreement between Marc Hedrick and Plus Therapeutics, Inc (Filed With SEC on May 14, 2020)
- Second Amendment to the Plus Therapeutics, Inc. 2015 New Employee Incentive Plan, dated February 6, 2020 (Filed With SEC on March 30, 2020)
- Employment Agreement between Plus Therapeutics, Inc. and Andrew Sims (Filed With SEC on March 12, 2020)
- Employment Agreement between Plus Therapeutics, Inc. and Marc Hedrick (Filed With SEC on March 12, 2020)
- 2014 Equity Incentive Plan of Plus Therapeutics, Inc., as Amended and Restated (Filed With SEC on August 15, 2019)
- FIRST AMENDMENT TO THE Cytori Therapeutics, INC. 2015 New EMPLOYEe INcentive Plan (Filed With SEC on March 24, 2017)
- THIRD AMENDMENT TO THE 2014 EQUITY INCENTIVE PLAN OF CYTORI THERAPEUTICS, INC. (Filed With SEC on March 24, 2017)
- Form of Agreement for Acceleration and/or Severance (Filed With SEC on March 11, 2016)
- Confidential Separation Agreement and General Release of all claims dated October 2, 2014, by and among the Company, and Clyde Shores (Filed With SEC on November 7, 2014)
- Offer Letter dated August 11, 2014, containing compensation terms for Mr. Tiago Girao, VP of Finance and Chief Financial Officer (Filed With SEC on November 7, 2014)
- AGREEMENT FOR ACCELERATIONAND/OR SEVERANCE (Filed With SEC on March 14, 2008)
- AGREEMENT FOR ACCELERATIONAND/OR SEVERANCE (Filed With SEC on March 14, 2008)
- AGREEMENT FOR ACCELERATIONAND/OR SEVERANCE (Filed With SEC on March 14, 2008)
- CONSULTING AGREEMENT (Filed With SEC on August 14, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2006)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2006)
- CYTORI THERAPEUTICS, INC. CONSULTING SERVICES AGREEMENT (Filed With SEC on November 14, 2005)
- SEVERANCE AGREEMENT AND MUTUAL RELEASE (Filed With SEC on November 14, 2005)
- MACROPOREBIOSURGERY, INC. 1997 STOCK OPTIONAND STOCK PURCHASE PLAN INCENTIVE STOCKOPTION AGREEMENT Four Year Vestingwith One Year Cliff (Filed With SEC on November 15, 2004)
- MACROPOREBIOSURGERY, INC. 1997 STOCK OPTIONAND STOCK PURCHASE PLAN INCENTIVE STOCKOPTION AGREEMENT 4 Year Vesting Month to Month (Filed With SEC on November 15, 2004)
- 2004 Equity Incentive Plan of Macropore Biosurgery, Inc. (Filed With SEC on August 27, 2004)
- MACROPORE, INC. CONSULTING SERVICES AGREEMENT (Filed With SEC on March 31, 2003)
